Metoprolol prophylaxis against postoperative atrial fibrillation increases length of hospital stay in patients not on pre-operative β blockers: The β blocker length of stay (BLOS) trial

Heart

Volumn 90, Issue 8, 2004, Pages 941-942

  Crystal, E ^a,c   Thorpe, K E ^b   Connolly, S J ^b   Lamy, A ^b   Cybulsky, I ^b   Carroll, S ^b   Roberts, R ^b   Gent, M ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART SURGERY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREMEDICATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DOUBLE-BLIND METHOD; HUMANS; LENGTH OF STAY; METOPROLOL; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 3442901140     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.016048     Document Type: Article

References (2)

1. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 1999;34:1262-347.
2. Connolly SJ, Cybulsky I, Lamy A, et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-blocker length of stay (BLOS) study. Am Heart J 2003;145:226-32.